Fuisz Pharma LLC Announces Patent Filing for Novel System and Method to Obtain Blood for Diagnostic Analysis Using a Lancet or Needle Puncture
MIAMI, Jan. 14, 2014 /PRNewswire/ -- Fuisz Pharma announced that it has filed a new patent application with the United States Patent & Trademark Office for a state of the art system, method and kit to obtain blood samples from a finger stick. The blood obtained is greater in volume and includes a system of management of capillary tubes and of obtaining refreshed capillary field blood that more closely approximates the diagnostic gold standard, venous blood, than traditional finger stick draws do.
Joseph Fuisz, managing member for Fuisz Pharma LLC, commented: "This is an exciting breakthrough in an area that had been static for far too long. It enables a substantial increase in harvested blood draw from a single stick. We feel this invention will be useful if the finger stick becomes commonplace in broad-based blood analytics."
Richard Fuisz M.D. added: "I am old enough and experienced enough in life to know that horses precede carts. If in the future blood diagnostics is based broadly in many parameters from a finger stick, then a better way needed to be invented to increase the yield of blood volume and improve the blood quality from a finger stick. We feel we have not just the better way but the essential way to accomplish the task."
Fuisz Pharma LLC is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, and have extensive experience working with big and specialty pharma. Fuisz Pharma is also active in diagnostic systems. Fuisz Pharma has its headquarters in Miami. www.fuisz.com.
SOURCE Fuisz Pharma LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article